DEXCOM INC (DXCM)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for DXCM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DXCM | Director; Executive Vice President and CEO of Verizon Business; Chair | 59 | ["Executive leadership roles across Verizon","Deep technical expertise in network technology and infrastructure"] | ["Chairman of CTIA","President’s National Security Telecommunications Advisory Council (NSTAC)","Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Kyle Malady has served on our Board since October 2020. Currently, Mr. Malady serves as EVP and CEO of the Verizon Business Group, a unit of Verizon Communications Inc., a telecommunications company. Previously Mr. Malady served as Executive Vice President of Global Networks and Technology and Chief Technology Officer at Verizon since August 2018. Prior to assuming this role, Mr. Malady was head of the Core Engineering and Operations organization within the Global Network and Technology organization at Verizon from May 2012 to July 2018 . He has also served as Verizon s Vice President of New Product Development from June 2005 to April 2012 . Mr. Malady is currently the Vice Chair of the board of the CTIA, the wireless industry s trade association. Mr. Malady also serves on the President s National Security Telecommunications Advisory Council (NSTAC). Mr. Malady received a B.S. in Mechanical Engineering from the University of Bridgeport and an MBA in Finance from the NYU Stern School of Business. Mr. Malady s experience in numerous fields at Verizon provides him with insights and guidance that qualify him to serve on the Board.